Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.

Recent studies have revealed that familial hypertrophic cardiomyopathy (FHC) is caused by missence mutations in myosin heavy chain or other sarcomeric proteins. To investigate the functional impact of FHC mutations in myosin heavy chain, mutants of Dictyostelium discoideum myosin II equivalent to human FHC mutations were generated by site-directed mutagenesis, and their motor function was characterized at the molecular level. These mutants, i.e., R397Q, F506C, G575R, A699R, K703Q, and K703W are respectively equivalent to R403Q, F513C, G584R, G716R, R719Q, and R719W FHC mutants. We measured the force generated by these myosin mutants as well as the sliding velocity and the actin-activated ATPase activity. These measurements showed that the A699R, K703Q, and K703W myosins exhibited unexpectedly weak affinity with actin and the lowest level of force, though their ATPase activity remained rather high. F506C mutant which has been reported to have benign prognosis exhibited the least impairment of the motile and enzymatic activities. The motor functions of R397Q and G575R myosins were classified as intermediate. These results suggest that the force level of mutant myosin molecule may be one of the key factors for pathogenesis which affect the prognosis of human FHC.

[1]  J. Seidman,et al.  Mutations in cardiac myosin heavy chain genes cause familial hypertrophic cardiomyopathy. , 1991, Molecular biology & medicine.

[2]  J. Spudich,et al.  Purification of a Functional Recombinant Myosin Fragment from Dictyostelium discoideum a , 1990, Annals of the New York Academy of Sciences.

[3]  I. Rayment,et al.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Roger Cooke,et al.  Crystal structure of the motor domain of the kinesin-related motor ncd , 1996, Nature.

[5]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[6]  J. Beckmann,et al.  Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[7]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[8]  J. Spudich,et al.  Fluorescent actin filaments move on myosin fixed to a glass surface. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Toyoshima,et al.  Site-directed mutations of Dictyostelium actin: disruption of a negative charge cluster at the N terminus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Crystal structure of the kinesin motor domain reveals a structural similarity to myosin , 1996 .

[11]  J. Spudich,et al.  Expression and characterization of a functional myosin head fragment in Dictyostelium discoideum. , 1989, Science.

[12]  S Kamimura,et al.  Direct measurement of nanometric displacement under an optical microscope. , 1987, Applied optics.

[13]  K. Svoboda,et al.  Fluctuation analysis of motor protein movement and single enzyme kinetics. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Reisler,et al.  Actin's view of actomyosin interface. , 1995, Biophysical journal.

[15]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[16]  H M Holden,et al.  X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. , 1995, Biochemistry.

[17]  S. Ishiwata,et al.  Stepwise motion of an actin filament over a small number of heavy meromyosin molecules is revealed in an in vitro motility assay. , 1994, Journal of biochemistry.

[18]  J. Seidman,et al.  Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. , 1993, American journal of human genetics.

[19]  L. Leinwand,et al.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.

[20]  J. Spudich,et al.  The neck region of the myosin motor domain acts as a lever arm to generate movement. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Lee,et al.  Predicting protein mutant energetics by self-consistent ensemble optimization. , 1994, Journal of molecular biology.

[22]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[23]  J. Spudich,et al.  Gene replacement in Dictyostelium: generation of myosin null mutants. , 1989, The EMBO journal.

[24]  S. Solomon,et al.  A molecular basis for familial hypertrophic cardiomyopathy: An α β cardiac myosin heavy chain hybrid gene , 1990, Cell.

[25]  P. Rogan,et al.  A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. , 1994, Human molecular genetics.

[26]  J. Spudich,et al.  Myosin step size. Estimation from slow sliding movement of actin over low densities of heavy meromyosin. , 1990, Journal of molecular biology.

[27]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C A Smith,et al.  X-ray structure of the magnesium(II).ADP.vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 A resolution. , 1996, Biochemistry.

[29]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[30]  K. Kometani,et al.  The initial phosphate burst in ATP hydrolysis by myosin and subfragment-1 as studied by a modified malachite green method for determination of inorganic phosphate. , 1986, Journal of biochemistry.

[31]  E. Reisler,et al.  C-terminus on actin: spectroscopic and immunochemical examination of its role in actomyosin interactions. , 1994, Advances in experimental medicine and biology.

[32]  J. Spudich,et al.  A functional recombinant myosin II lacking a regulatory light chain-binding site. , 1993, Science.

[33]  T. Yanagida,et al.  Charge-reversion mutagenesis of Dictyostelium actin to map the surface recognized by myosin during ATP-driven sliding motion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Fananapazir,et al.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.

[35]  S. Solomon,et al.  A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. , 1990, Cell.

[36]  R. Firtel,et al.  Establishment of a transient expression system for Dictyostelium discoideum. , 1988, Nucleic acids research.

[37]  J. Seidman,et al.  A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3 , 1993, Nature Genetics.

[38]  E. Reisler,et al.  Role of charged amino acid pairs in subdomain-1 of actin in interactions with myosin. , 1995, Biochemistry.

[39]  Michael Whittaker,et al.  A 35-Å movement of smooth muscle myosin on ADP release , 1995, Nature.

[40]  J. Spudich,et al.  Role of highly conserved lysine 130 of myosin motor domain. In vivo and in vitro characterization of site specifically mutated myosin. , 1994, The Journal of biological chemistry.

[41]  J. Spudich,et al.  The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. , 1971, The Journal of biological chemistry.

[42]  S. Solomon,et al.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. , 1994, The Journal of clinical investigation.